Winship Logo

Emory Glenn Family Breast Center Publications

July 20252 publications

AuthorsDate PublishedJournalTitle
Timothy L Lash
07/01/2025Breast cancer research and treatmentGenetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patients.
Sagar A Patel
Lauren M Postlewait
Cletus A Arciero
Theresa W Gillespie
07/01/2025Clinical breast cancerPostmastectomy Radiation Therapy for Intermediate-Risk Breast Cancer Patients With 0-3 Positive Axillary Lymph Nodes: Emulating the SUPREMO Trial Using Real-World Data.

June 202512 publications

AuthorsDate PublishedJournalTitle
Mylin A Torres
06/18/2025JCO oncology practiceSentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights.
Joseph Lipscomb
Ilana Graetz
06/17/2025Health services researchCOVID-19-Related Financial Hardship and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage Breast Cancer.
Sunil Badve
Xiaoxian Li
06/12/2025Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncAnalytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With an FDA-Approved Benchmark.
Xiaoxian Li
Jane L Meisel
Mylin A Torres
David M Schuster
06/06/2025Clinical nuclear medicineNegative 18F-FES PET/CT Despite Estrogen Receptor Positivity by Immunohistochemistry.
K Kalinsky
06/05/2025ESMO openEffectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States.
Mylin A Torres
Jolinta Y Lin
Reshma Jagsi
06/05/2025The New England journal of medicineOmitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
K Kalinsky
06/02/2025ESMO openThe association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.
Yong Wan
06/02/2025The Journal of clinical investigation4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response.
Mylin Torres
06/01/2025Contemporary clinical trialsEffectiveness of out-of-pocket cost COMmunication and financial navigation (CostCOM) in cancer patients: Study protocol for ECOG-ACRIN EAQ222CD.
Kevin C Ward
06/01/2025JCO oncology practiceOncology and Primary Care Involvement in Breast Cancer Survivorship Care More Than 5 Years After Initial Treatment.
Ilana Graetz
06/01/2025Journal of cancer survivorship : research and practiceSilent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
Kevin Kalinsky
06/01/2025The New England journal of medicineFirst-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast Cancer.

May 202513 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
05/31/2025The New England journal of medicineOverall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast Cancer.
Xiaoxian Li
Ritu Aneja
05/30/2025Cell communication and signaling : CCSC/EBPβ increases tumor aggressiveness by enhancing KIFC1 expression in androgen receptor negative triple negative breast cancer.
Xiaoxian Li
05/23/2025The American journal of surgical pathologyClinicopathologic and Whole Exome Sequencing Analyzes of High-Grade Serous Carcinoma-Like Carcinoma of the Breast Reveal Unique Genetic Profile and Poor Clinical Outcome.
Mylin A Torres
05/10/2025Journal of clinical oncology : official journal of the American Society of Clinical OncologySentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.
Anant Mandawat
05/06/2025Journal of the American Heart AssociationProteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study.
Anant Madabhushi
05/02/2025European journal of cancer (Oxford, England : 1990)Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained images.
Cletus A Arciero
05/01/2025Annals of surgical oncologyOncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from &gt; 1500 Patients on the I-SPY2 Clinical Trial.
David H Howard
05/01/2025Cancer causes &amp; control : CCCEligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.
Timothy L Lash
05/01/2025Epidemiology (Cambridge, Mass.)A Quasi-experimental Study of General Practices' Referral to Mammography in the Posttrial Treatment Era.
Kevin C Ward
05/01/2025Journal of clinical oncology : official journal of the American Society of Clinical OncologyBreast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in <i>ATM</i>, <i>CHEK2</i>, or <i>PALB2</i>.
Kevin Kalinsky
05/01/2025Journal of the National Cancer InstituteRace and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.
Sunil S Badve
Xiaoxian Li
05/01/2025Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncClassification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.
Timothy L Lash
05/01/2025Pharmacoepidemiology and drug safetyDrug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach.

April 20259 publications

AuthorsDate PublishedJournalTitle
Yueming Zhu
Adam Marcus
Kevin Kalinsky
Yong Wan
04/15/2025Nature communicationsMGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer.
Aparna H Kesarwala
Susan N Thomas
David S Yu
Zachary S Buchwald
04/14/2025Nature communicationsCombination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node.
Sunil S Badve
Xiaoxian Li
04/13/2025HistopathologyMalignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.
Jane L Meisel
04/01/2025Clinical breast cancerEffects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study.
Shipra Gandhi
04/01/2025HistopathologyBreast biomarkers evolution between primary and distant metastasis: incidence and significance.
Anant Madabhushi
04/01/2025JBMR plusADAM: automated digital phenotyping and morphological texture analysis of bone biopsy images using deep learning.
Reshma Jagsi
04/01/2025JCO oncology practiceFinancial Toxicity Screening Preferences in Patients With Breast Cancer.
Hari Trivedi
04/01/2025PLOS digital healthSubgroup evaluation to understand performance gaps in deep learning-based classification of regions of interest on mammography.
Christine C Ekenga
04/01/2025Preventive medicine reportsAssociations between social capital and screening mammography among older U.S. women.

March 202511 publications

AuthorsDate PublishedJournalTitle
Reshma Jagsi
03/31/2025Journal of the National Cancer InstituteDevelopment of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic Score.
Kevin C Ward
03/31/2025Journal of the National Cancer InstituteExtended endocrine therapy use and decision making after breast cancer diagnosis.
Shipra Gandhi
03/28/2025Journal of the National Comprehensive Cancer Network : JNCCNHSR25-170: Investigating Socioeconomic and Racial Disparities in Pathologic Response and Survival Outcomes in Triple-Negative Breast Cancer Post-Neoadjuvant Chemotherapy: Insights From the National Cancer Database.
Kevin Kalinsky
03/20/2025Journal of clinical oncology : official journal of the American Society of Clinical OncologyAbemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.
Sunil Badve
03/18/2025JAMAActive Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Katherine A Yeager
Ilana Graetz
03/14/2025Clinical journal of oncology nursingOptimizing Assessment of and Education About Chemotherapy-Induced Peripheral Neuropathy Among Breast Cancer Survivors.
Kevin M Kalinsky
03/10/2025Journal of clinical oncology : official journal of the American Society of Clinical OncologyDevelopment and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.
Jinbing Bai
Deborah W Bruner
Mylin A Torres
Zachary S Buchwald
Jolinta Y Lin
03/08/2025International journal of radiation oncology, biology, physicsSkin Microbiome, Inflammation, and Skin Toxicities in Women With Breast Cancer Receiving Moderately Hypofractionated Radiation Therapy.
Yueming Zhu
Theresa W Gillespie
Lauren E McCullough
Mylin A Torres
Yong Wan
03/01/2025Advanced science (Weinheim, Baden-Wurttemberg, Germany)Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP.
Jane Meisel
03/01/2025JCO oncology practiceSubcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).
Kevin Kalinsky
03/01/2025JCO precision oncologyComprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated Tumor.

February 20257 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
Jane Meisel
02/28/2025Scientific reportsGene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer.
Kevin Kalinsky
02/25/2025European journal of cancer (Oxford, England : 1990)Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trials.
Timothy L Lash
02/06/2025Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyCYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-Analysis.
Lauren E McCullough
02/03/2025JAMA network openPhysical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors.
Jinbing Bai
02/01/2025British journal of health psychologyAttributes and influencing factors of hope levels in breast cancer patients: A latent profile analysis.
Kevin M Kalinsky
02/01/2025JCO oncology practiceUse of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer.
Hari Trivedi
02/01/2025Journal of the American College of Radiology : JACRMulti-Institutional Evaluation and Training of Breast Density Classification AI Algorithm Using ACR Connect and AI-LAB.

January 20259 publications

AuthorsDate PublishedJournalTitle
Reshma Jagsi
01/24/2025JCO oncology practiceValidation of a Single Item Measure for Financial Toxicity Screening in Patients With Breast Cancer.
Kevin Kalinsky
01/20/2025Journal of clinical oncology : official journal of the American Society of Clinical OncologyDatopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.
Jeffrey M Switchenko
Kevin C Ward
Timothy L Lash
Lauren E McCullough
01/10/2025American journal of epidemiologyA registry-based approach for estimating county-level race disparities in breast cancer mortality: an analysis in Georgia.
Timothy L Lash
01/01/2025Breast cancer research and treatmentGenetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort study.
Jane Meisel
01/01/2025Breast cancer research and treatmentGenomic and transcriptomic landscape of HER2-low breast cancer.
Lauren E McCullough
01/01/2025CA: a cancer journal for cliniciansCancer statistics for African American and Black people, 2025.
J L Meisel
01/01/2025ESMO openDrug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
Xiaofeng Yang
01/01/2025Journal of applied clinical medical physicsMachine learning in image-based outcome prediction after radiotherapy: A review.
Jane Lowe Meisel
01/01/2025Therapeutic advances in medical oncologyTROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2- breast cancer.